Evaluating a group-based maintenance self-management intervention for patients with COPD

SPACE FOR COPD© delivered as a maintenance programme on Pulmonary Rehabilitation discharge: a randomised controlled trial evaluating the long-term effects on exercise tolerance and mental wellbeing

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN30110012

Enrollment

116

Registered

2019-08-12

Start date

2019-10-18

Completion date

Unknown

Last updated

2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease Respiratory

Interventions

Current interventions as of 10/06/2021: Eligible and willing participants will be consented and then randomised to either usual care or the SPACE FOR COPD maintenance programme. Randomisation will be

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 18 years and older 2. Completed PR within the last 4 weeks 3. Clinical diagnosis of COPD 4. Able to read and write English to the age of an eight-year-old

Exclusion criteria

Exclusion criteria: 1. Significant disability which limits the daily physical activity

Design outcomes

Primary

Measure	Time frame
Endurance walking distance at 12 months in those who have completed the maintenance programme compared to usual care (measured by Endurance Shuttle Walking Test).	—

Secondary

Measure	Time frame
At 12-months: 1. Maximum walking distance measured using incremental Shuttle Walking Test distance 2. Quality of life measured using EQ-5D 3. Anxiety and depression measured using the Hospital Anxiety and Depression Scale 4. Physical activity measured over 7 days using accelerometer devices (e.g. steps, calories, and MET levels). 5. Symptoms (breathlessness, fatigue, sputum production, cough, sleep, chest tightness) measured using the Chronic Respiratory Disease Questionnaire 6. Patient activation (knowledge, skills and confidence to manage COPD) measured using the Patient Activation Measure (PAM-13) questionnaire 7. Forced Expiratory Volume in 1 second (FEV1) measured using a spirometer. 8. Adherence to the SPACE FOR COPD maintenance programme in terms of sessions attended, completion of the programme and exercise diary entries. 9. Data for future health economic analysis in both groups; including hospital admissions, health care contacts, medication use and mortality collected from patient self-report. Qualitative outcomes: 10. To understand the patient experience of SPACE FOR COPD; to identify facilitators and barriers of the package to maintain health and well-being. 11. To work with staff, managers and commissioners involved in the delivery of SPACE FOR COPD as a maintenance option to explore how, if successful, this programme could be rolled-out more widely.	—

Measure

Time frame

At 12-months: 1. Maximum walking distance measured using incremental Shuttle Walking Test distance 2. Quality of life measured using EQ-5D 3. Anxiety and depression measured using the Hospital Anxiety and Depression Scale 4. Physical activity measured over 7 days using accelerometer devices (e.g. steps, calories, and MET levels). 5. Symptoms (breathlessness, fatigue, sputum production, cough, sleep, chest tightness) measured using the Chronic Respiratory Disease Questionnaire 6. Patient activation (knowledge, skills and confidence to manage COPD) measured using the Patient Activation Measure (PAM-13) questionnaire 7. Forced Expiratory Volume in 1 second (FEV1) measured using a spirometer. 8. Adherence to the SPACE FOR COPD maintenance programme in terms of sessions attended, completion of the programme and exercise diary entries. 9. Data for future health economic analysis in both groups; including hospital admissions, health care contacts, medication use and mortality collected from patient self-report. Qualitative outcomes: 10. To understand the patient experience of SPACE FOR COPD; to identify facilitators and barriers of the package to maintain health and well-being. 11. To work with staff, managers and commissioners involved in the delivery of SPACE FOR COPD as a maintenance option to explore how, if successful, this programme could be rolled-out more widely.

—

Countries

England, United Kingdom

Contacts

Public ContactKhaled Alqahtani

kada5@leicester.ac.uk01162582762

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 12, 2026